#ShockwaveC2AeroFly# has taken flight across America. Next stop: #TCT2026# ✈️ Congratulations to the physicians and cath lab teams behind the first commercial cases, experiencing the benefits of 2x-faster pulsing firsthand. Join us at TCT as #ShockwaveCoronaryIVL# continues to lead the conversation around the treatment of complex coronary calcification. Attend the Training Pavilion sessions or visit our booth to experience our next-generation #CoronaryIVL# catheter firsthand. ⚡ Explore all we're bringing to TCT:  Drs. Ziad Ali (@ziadalinyc), Rich Shlofmitz, Evan Shlofmitz (@ESHLOF), Paul Sapia (@PaulSap9), Allen Jeremias (@DrAllenJ), Annapoorna Kini (@DoctorKini), Samin Sharma, Amit Hooda (@AmithoodaMD), Prashant Kaul (@KaulP), Hector Tamez (@hectortamezmd), Robert Stoler, Subhash Banerjee, Chadi Dib, Karim Al-Azizi (@kalazizimd), Emmanouil Brilakis (@esbrilakis), and Yousif Ahmad US Rx only. Safety Info: Product availability may vary by country.

🔔 Friendly reminder to stop by our booth at BSIR 2026 On 5 November, don't miss the opportunity to: •Attend the hands-on workshop on optimal #ShockwaveIVL# vessel preparation •Engage in dynamic learning at the Active Learning Zone •Connect with our team and discuss the latest CLTI patient data And yes, you'll find us in our new full red look! #ShockwaveIVL# #JNJMedTechProud# #BSIR2026# #CLTIPatient# #VesselPrep# US Rx only. Safety Info:  Product availability may vary by country.

Discover how Dr. Sung Yup (Pablo) Kim and Dr. Akila Pai (@akila_pai) used #ShockwaveJavelin# Peripheral IVL to modify and cross a severely calcified tibial lesion in a complex CLTI case. Read about the case in @VascularOnline:  Dr. Sung Yup (Pablo) Kim is a paid consultant of Johnson & Johnson. US Rx only. Safety Info: Product availability may vary by country.

Take #ShockwaveC2AeroFly# for a test flight at #TCT2026#. ⚡✈️ Join the PCI Skills Pavilion and hear from Drs. James Spratt (@jcspratt), Leah Raj, Thuy Ryan (@ThuyPhamDO), Carlos Collet (@ColletCarlos), Salman Arain (@DrSalmanArain), and Dhananjay Chatterjee (@dchatterjee824) as they discuss how angiography, CCTA, and intravascular imaging can help identify and assess calcium, followed by hands-on experience with #ShockwaveC2AeroFly#. 📅 Monday, November 2 | 2:00-3:30 PM and 4:00-5:30 PM Build your TCT flight plan and join our circulatory restoration solutions Training Pavilion:  @TCTConference #ShockwaveIVL# #JNJMedTech# Presenting physicians are paid consultants of Johnson & Johnson. US Rx only. Safety Info: Product availability may vary by country.

For International Physicians: In this #ShockwaveReducer# interview, Prof. Stefan Verheye discusses how randomized trials and real-world registries together provide a comprehensive picture of Shockwave Reducer outcomes and patient benefit. Watch the full interview:  Safety Info: CAUTION: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada.

Treating #CLTI# starts with addressing one of its biggest challenges: vascular calcification. Because calcium limits vessel compliance and can complicate endovascular treatment, effective calcium modification has become critical to achieving durable outcomes. With its mechanism of action, #ShockwaveIVL# selectively fractures calcium while minimizing vessel injury, helping optimize treatment across the peripheral vasculature, including below-the-knee interventions with #ShockwaveE8# on patients with CLTI. 💡Read more in the Vascular News September supplement. #CLTI# #PAD# #ShockwaveIVL# #PeripheralIVL# #VascularHealth# #MoA# #JNJMedTechProud# US Rx only. Safety Info:  Product availability may vary by country.

The #DisruptBTKII# conversation continues with new 2-year results. ⚡ Hear the reactions from Drs. Venita Chandra, Kyle Reynolds (@KReyMD), and Chris Papryzcki (@CincyVascSurg) on the 24-month outcomes presented as a Late Breaker at #VIVA26#, including sustained clinical benefits, significant quality-of-life gains, low reintervention rates, and ongoing limb preservation in patients with calcified BTK disease. Learn more: @VIVAPhysicians #PeripheralIVL# US Rx only. Safety Info: Product availability may vary by country.

Read how Dr. Charles Bailey used #ShockwaveJavelin# to help restore blood flow through the distal AT, DP, and pedal-plantar loop in a patient with CLTI and recurrent toe ulceration. Case highlights: ⚡ 120 #ShockwaveIVL# pulses were delivered across the calcified occlusive segments. ⚡ Blood flow was restored through the distal AT, DP, and pedal-plantar loop. ⚡ Great toe pressure increased to 71 mm Hg, with restored patency and multiphasic flow across the AT and DP post procedure. Read the full @EVToday article for additional case examples and clinical perspectives from Dr. Charles Bailey and Dr. Karan Garg:  Drs. Charley J. Bailey and Karan Garg are paid consultants of Johnson & Johnson. US Rx only. Safety Info: Product availability may vary by country.

For International Physicians: In this #ShockwaveReducer# interview, Prof. Tommaso Gori (@tommasoggori) discusses the clinical evidence supporting Shockwave Reducer therapy and the importance of addressing the unmet needs of patients living with refractory angina. Watch the full interview:  Safety Info: CAUTION: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada.

First impressions are in. ✈️ Shout out to the operators and cath lab teams who were among the first to perform #ShockwaveC2AeroFly# commercial cases and experience the benefits of 2x faster pulsing. Drs. Ziad Ali (@ziadalinyc), Rich Shlofmitz, Evan Shlofmitz (@ESHLOF), Paul Sapia (@PaulSap9), Allen Jeremias (@DrAllenJ), Annapoorna Kini (@DoctorKini), Samin Sharma, Amit Hooda (@AmithoodaMD), Prashant Kaul (@KaulP), Hector Tamez (@hectortamezmd), Robert Stoler, Subhash Banerjee, Chadi Dib, Karim Al-Azizi (@kalazizimd), Emmanouil Brilakis (@esbrilakis), and Yousif Ahmad Treatment time includes pulsing time and pause time. Pause time may vary by patient need. US Rx only. Safety Info: Product availability may vary by country.

Bye, bye blue — when you see us at #TCT2026#, we'll be red with excitement! Shockwave Medical is now @JNJMedTech, so make sure to stop by our booth to see our new shade of bold and learn how our impact has been amplified by the global leader in healthcare⚡​ Discover what we have red-y for you at this year's conference:

Meet #ShockwaveC2AeroFly#, the next-generation #CoronaryIVL# catheter designed to treat calcified coronary disease more efficiently. What makes it different? Faster pulsing, shorter pause time, reduced patient ischemic time, and leading deliverability, crossability and repositioning capabilities of the #ShockwaveC2Aero# platform come together to enable physicians to treat calcified CAD faster through patient-focused innovation. Learn more on our website:  Read the Press Release: US Rx only. Safety Info:  availability may vary by country.

A Featured Clinical Research session you won't want to miss at #TCT2026#: FORWARD CAD 30-day results. ⚡ Join Dr. Robert W. Yeh (@rwyeh) as he presents new 30-day results from the FORWARD CAD IDE study evaluating Shockwave Javelin Coronary IVL in challenging coronary lesions and discusses the future of this innovative technology. 📅 Sunday, November 1 ⏰ 12:58 PM PT 📍 Coronary Live Case Theater, Ground Level, Halls A-B, San Diego Convention Center Meet us as @JNJMedTech circulatory restoration solutions for the first time and plan your TCT schedule with our featured studies, sessions, and education:  @TCTConference #ShockwaveIVL# #JNJMedTech# Caution: Investigational device. Limited by Federal (U.S) law to investigational use only. Outside the U.S., the device is subject to local regulatory requirements and is not commercially available.

The #ShortCUT# trial sparked a lot of conversation, but not a change in perspective for Dr. William Dixon. In this new @CardioBusiness article, the Blue Collar I.C. podcast host explains why he remains confident in a #ShockwaveIVL-first# approach and continues to view it as the “gold standard” for calcium modification. 🔗  Dr. William C. Dixon is a paid consultant of Johnson & Johnson. US Rx only. Safety Info: Product availability may vary by country.

#ShockwaveC2AeroFly# is set for takeoff. ⚡✈️ Don't miss Drs. Yousif Ahmad, Ziad Ali (@ziadalinyc), Emmanouil Brilakis (@esbrilakis), and Rhian Davies (@RhianEDavies1) at #TCT2026# as they discuss complex coronary calcium, the critical clinical evidence behind the Shockwave IVL portfolio, and the next era of treatment with Shockwave C2 Aero Fly. 📅 Monday, November 2 | 12:45–1:45 PM Meet us as @JNJMedTech circulatory restoration solutions for the first time and see what's on board for #TCT#:  @TCTConference #ShockwaveIVL# #JNJMedTech# Presenting physicians are paid consultants of Johnson & Johnson. US Rx only. Safety Info: Product availability may vary by country.

John Adams went from co-founder to a patient of his own invention. Read his incredible story, and learn why intravascular lithotripsy (IVL) is so groundbreaking for cardiovascular disease. ​ Read the full article at the link: ​

New 12-month FORWARD PAD outcomes reinforce the performance of #ShockwaveJavelin# as a safe and effective tool for modifying calcium and crossing challenging lesions in complex PAD. ⚡ At one year, treatment with Javelin resulted in fCD-TLR of 85%, despite being used in a cohort with advanced PAD (42% CTOs and 84% with severe calcification). Read the 12-month outcomes in @MyJSCAI: Thank you to all study investigators for their contributions and commitment to improving outcomes for patients with PAD: Drs. Andrew Holden, Daniel Clair (@scarolinavasc), JD Corl (@JDCorlMD), Sameh Sayfo (@Samsayfo), Bibombe P. Mwipatayi, Manar Khashram (@ManarKhashram), Nicolas Shammas (@nicolas_shammas), Anderson Mehrle, Anvar Babaev, Peter Soukas (@PeterSoukas), Richard Pin, and Nick West US Rx only. Safety Info: Product availability may vary by country.

Don't miss these key data presentations at #TCT2026#. 📍 From featured research to real-world evidence, join these four sessions to discover the latest innovations across our Shockwave IVL portfolio: ⚡ NODULE-SHOCK, presented by Dr. Annapoorna Kini (@DoctorKini) ⚡ AeroCAD, presented by Dr. Ziad Ali (@ziadalinyc) ⚡ CAD DUO 1-Year Results, presented by Dr. Rhian E. Davies (@RhianEDavies1) ⚡ FORWARD CAD 30-Day Results, presented by Dr. Robert W. Yeh (@rwyeh) Stay updated on all things TCT:  @TCTConference #JNJMedTech# US Rx only. Safety Info: Product availability may vary by country.

See how Dr. Sung Yup (Pablo) Kim and Dr. Akila Pai (@akila_pai) used #ShockwaveJavelin# Peripheral IVL in a complex CLTI case to help restore inline flow and support preservation of a patient's remaining limb. Read the @VascularOnline advertorial:  Dr. Sung Yup (Pablo) Kim is a paid consultant of Johnson & Johnson. US Rx only. Safety Info: Product availability may vary by country.

We've swapped blue for a bold new look — Shockwave Medical has officially rebranded to @JNJMedTech. Though our brand color is now red, our pioneering technology is still called #ShockwaveIVL#, our product names will stay the same, and our relentless commitment to innovation remains unchanged.